Skip to main content
FinSpry Logo
FinSpry
RLAY logo
RLAY
(NASDAQ)
Relay Therapeutics, Inc.
$12.54-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Relay Therapeutics (RLAY) Stock Price & Financial Analysis

Relay Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.48 - $13.04
52-Week High$11.49
52-Week Low$1.78
Open$10.50
Volume8.89M
Average Volume (3M)8.89M
Market Cap2.15B
Shares Outstanding171.59M
Price to Sales (P/S)120.34
Price to Book (P/B)3.26
EV/EBITDA-6.05
Revenue (TTM)15.36M
Net Income (TTM)-276.48M
Free Cash Flow (TTM)-235.87M
EPS (TTM)$-1.61
Profit Margin-1800.46%
Operating Margin-1971.46%
Return on Equity (ROE)-48.76%
Debt to Equity0.06
50-Day MA$9.24
200-Day MA$6.45
52-Week Change336.03%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Relay Therapeutics

What is the current stock price for RLAY?

As of the latest trading session, RLAY stock trades at $12.54. The 52-week range is $1.78–$11.49, with a day range of $10.48–$13.04.

What is the P/E ratio for RLAY?

The P/E ratio (Price-to-Earnings) for RLAY is shown in the Key Statistics section. This valuation metric helps compare Relay Therapeutics, Inc. to industry peers.

Does RLAY pay dividends?

Relay Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RLAY?

Based on 5 analysts, the consensus for RLAY is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RLAY?

Relay Therapeutics's market capitalization is $2.15B, classifying it as a mid-cap company. Relay Therapeutics operates in the Healthcare sector within the Biotechnology industry.